Associate Professor, Medicine, Vanderbilt University School of Medicine
Oncology
Dr. Adetola A. Kassim, MD
|
|
Give Review
Adetola Kassim works in the field of Oncology. He graduated from Albert Einstein College of Medicine. Adetola Kassim is a published MD. He published 34 publications, including: 'Alternative donor allogeneic hematopoietic cell transplantation for hemoglobinopathies.' He is registered with Medicare.
Publications
- Randomized Double-Blind Study of the Safety and Immunogenicity of Standard-Dose Trivalent Inactivated Influenza Vaccine versus High-Dose Trivalent Inactivated Influenz...
- Non-invasive imaging of oxygen extraction fraction in adults With sickle cell anaemia.
- Forced expiratory volume in 1 second is associated with earlier death in sickle cell Anemia.
- Factors associated with growth and blood pressure patterns in children with sickle cell Anemia: Silent Cerebral Infarct Multi-Center Clinical Trial cohort.
- Extracorporeal photopheresis as second-line treatment for Acute graft-versus-host disease: impact on six-month freedom from treatment failure.
- Post-allograft pomalidomide and reversible hepatotoxicity.
- Nocturnal enuresis in sickle cell Disease.
- Targeted Busulfan therapy With a steady-state concentration of 600-700 ng/mL in patients With sickle cell disease receiving HLA-identical sibling bone marrow transplant.
- The case for and against initiating either hydroxyurea therapy, blood transfusion therapy or hematopoietic stem cell transplant in asymptomatic children With sickle ce...
- Geographic Distance Is Not Associated with Inferior Outcome When Using Long-Term Transplant Clinic Strategy.
- Six-month freedom from treatment failure is an important end point for Acute GVHD clinical trials.
- New allergies after cord blood transplantation.
- Extracorporeal photopheresis versus anticytokine therapy as a second-line treatment for steroid refractory Acute GVHD: A multicenter comparative analysis.
- Salvage Second Hematopoietic Cell Transplantation in Myeloma.
- Minimal residual Disease in myeloma: are we there yet?
- Sickle Cell Disease, Vasculopathy, and Therapeutics.
- Tissue-specific regulatory T cells; biomarker for Acute graft-versus-host disease and survival.
- Predicting post-transplant diabetes mellitus by regulatory T Cell phenotype: implications for metabolic intervention to modulate alloreactivity.
- Does peritransplantation use of rituximab reduce the risk of EBV reactivation and PTLPD?
- Megalophallus as a sequela of priapism in sickle cell Anemia: use of blood oxygen level-dependent magnetic resonance imaging.
- Cytomegalovirus ventriculoencephalitis in a peripheral blood stem Cell transplant recipient.
- Incidence and outcome of Chronic graft-versus-host disease using National Institutes of Health consensus criteria.
- Genetic variation in recipient B-Cell activating factor modulates phenotype of GVHD.
- Regulatory T cell expression of CLA or α(4)β(7) and skin or gut Acute GVHD outcomes.
- Classic and overlap Chronic graft-versus-host disease (cGVHD) is associated with superior outcome after extracorporeal photopheresis (ECP).
- Extracorporeal photopheresis in patients With refractory bronchiolitis obliterans developing after allo-SCT.
- Pegfilgrastim after high-dose chemotherapy and autologous peripheral blood stem Cell transplant: phase II study.
- Pretransplantation C-Peptide level predicts early posttransplantation diabetes mellitus and has an impact on survival after allogeneic stem Cell transplantation.
- Reduced-intensity allogeneic hematopoietic stem cell transplantation for Acute leukemias: ''what is the best recipe?''.
- High-dose chemotherapy followed by autologous stem cell transplantation for relapsed or refractory Hodgkin Lymphoma: prognostic features and outcomes.
- Early lymphocyte reconstitution is Associated with improved transplant outcome after cord blood transplantation.
- Thyroid abnormalities in patients treated with lenalidomide for Hematological malignancies: results of a retrospective case review.
- Alternative donor allogeneic hematopoietic Cell transplantation for hemoglobinopathies.
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
- Plasmapheresis
Conditions Treated
- Acute Leukemia
- Anemia
- Antiphospholipid Syndrome (APS)
- Central Nervous System Lymphoma
- View All
Doctors Specialties
- Hematology
- Oncology
Accepted Insurances
Education
-
Albert Einstein College of Medicine -
University of Lagos College of Medicine
Hospital
-
Vanderbilt Hospital and Clinics
Drug Facts
| NPI NUMBER | 1730295742 | |
| NPPES Provider LastName | KASSIM | |
| NPPES Provider FirstName | ADETOLA | |
| NPPES Provider ZIPCode | 372320001 | |
| NPPES Provider State | TN | |
| Specialty Description | Hematology | |
| Total Claim Count | 526.0 | |
| Distinct Opioid Count | 5.0 | |
| Opioid Claim Count | 175.0 | |
| Percent Opioid Claims | 33.27 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1730295742 |
| Last Name Of The Provider | KASSIM |
| First Name Of The Provider | ADETOLA |
| View All |
Similar Doctors
|
Dr. Jack W. Erter, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anthony A. Meluch, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edward K. Barnes, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vicki L. Keedy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Emily Chan, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Ian W. Flinn, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Carlos L. Arteaga, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Michael N. Neuss, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Mia A. Levy, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Vandana G. Abramson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elizabeth B. Rinker, MD
This Doctor is OpenDoctor Recommended.
|